Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Latex rubber tubing 8mm
22903409042
|
Latex rubber tubing 8mm | Urinal Systems | Incontinence Appliances | No data available |
|
Laurilsulfate 10% solution
1311030A0AAAKAK
|
Generic liquid | Alkyl sulphate | Skin | No data available |
|
Lauromacrogol 400 5% / Heparinoid 0.2% rectal ointment
0107010J0AAABAB
|
Lauromacrogol/ Heparinoid | Heparinoid | Gastro-Intestinal System | No data available |
|
Lauromacrogol 400 50mg / Heparinoid 4mg suppositories
0107010J0AAAAAA
|
Lauromacrogol/ Heparinoid | Heparinoid | Gastro-Intestinal System | No data available |
|
Lavender compound tincture
190606000AAAUAU
|
Generic compound preparation BNF 1906060 | Other tincture preparations | Other Drugs and Preparations | No data available |
|
Lavender oil 80mg capsules
091200000AAFBFB
|
Generic compound preparation BNF 0912000 | Other health supplement preparations | Nutrition and Blood | No data available |
|
Lavender oil liquid
190605000AAAXAX
|
Generic compound preparation BNF 1906050 | Other oil preparations | Other Drugs and Preparations | No data available |
|
Laxagol oral powder sachets
0106040M0BEAAAA
|
Laxagol | Macrogol 3350 | Gastro-Intestinal System | No data available |
|
LBF No Sting barrier film spray
23800908012
|
LBF No Sting barrier film spray | Skin Fillers And Protectives | Stoma Appliances | No data available |
|
Leandra 30microgram/150microgram tablets
0703010F0CIAAAC
|
Leandra | Combined ethinylestradiol 30mcg | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Lecaent 150mg capsules
0408010AEBDAEAE
|
Lecaent | Pregabalin | Central Nervous System | No data available |
|
Lecaent 200mg capsules
0408010AEBDAFAF
|
Lecaent | Pregabalin | Central Nervous System | No data available |
|
Lecaent 225mg capsules
0408010AEBDAGAI
|
Lecaent | Pregabalin | Central Nervous System | No data available |
|
Lecaent 25mg capsules
0408010AEBDAAAA
|
Lecaent | Pregabalin | Central Nervous System | No data available |
|
Lecaent 300mg capsules
0408010AEBDAHAG
|
Lecaent | Pregabalin | Central Nervous System | No data available |
|
Lecaent 75mg capsules
0408010AEBDACAC
|
Lecaent | Pregabalin | Central Nervous System | No data available |
|
Ledaga 160micrograms/g gel
0801010W0BCAAAB
|
Ledaga | Chlormethine hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Lederfen 300mg capsules
1001010F0BBAAAA
|
Lederfen | Fenbufen | Musculoskeletal and Joint Diseases | No data available |
|
Lederfen 300mg tablets
1001010F0BBABAB
|
Lederfen | Fenbufen | Musculoskeletal and Joint Diseases | No data available |
|
Lederfen 450mg tablets
1001010F0BBADAC
|
Lederfen | Fenbufen | Musculoskeletal and Joint Diseases | No data available |
|
Lederfolin 350mg/35ml solution for injection vials
0801000I0BFABBE
|
Lederfolin | Calcium folinate | Malignant Disease and Immunosuppression | No data available |
|
Lederkyn 500mg tablets
0501080T0BBAAAA
|
Lederkyn | Sulfamethoxypyridazine | Infections | No data available |
|
Ledermycin 150mg capsules
0501030F0BBAAAA
|
Ledermycin | Demeclocycline hydrochloride | Infections | No data available |
|
Ledermycin 300mg capsules
0501030F0BBABAJ
|
Ledermycin | Demeclocycline hydrochloride | Infections | No data available |
|
Lederspan 100mg/5ml suspension for injection vials
1001022Y0BBACAC
|
Lederspan | Triamcinolone hexacetonide | Musculoskeletal and Joint Diseases | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.